Industry: Food & Beverages
Published Date: 2025-09-13
Pages: 105 Pages
Report ld: 4988150
Request Sample
Customized Report
KEY DRIVERS
Rising prevalence of minor ailments such as sore throat, cough, and digestive discomfort.
Popularity of functional foods and nutraceuticals.
Demand for convenient, easy-to-consume dosage forms compared to traditional syrups or tablets.
Expansion of sugar-free, low-calorie, and natural ingredient-based formulations.
Regional Trends
North America & Europe: High adoption due to OTC regulations, awareness of functional health products, and preference for premium, high-quality formulations.
Asia-Pacific: Fastest market growth driven by increasing healthcare spending, urbanization, and rising middle-class population seeking convenient medicinal solutions.
Emerging markets (Latin America, Middle East & Africa): Growing OTC market and rising awareness of self-care products fuel moderate growth.
The global Medicated Confectionery market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Medicated Confectionery Market Size(US$)

CAGR 2025-2031
5.2%
Market Size,2031
USD 9,372
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Medicated Confectionery market size was US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Medicated Confectionery refers to confectionery products formulated with active medicinal ingredients or functional compounds, intended to provide relief from minor ailments such as sore throat, cough, mouth dryness, indigestion, or to deliver vitamins and herbal extracts. Unlike regular candies, medicated confectionery combines the taste and texture of sweets with therapeutic or functional benefits, and is often classified as an OTC (over-the-counter) healthcare product. Common forms include lozenges, hard candies, chewing gums, and gummies with added active substances.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Medicated Confectionery market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Chewable Tablets in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Supermarkets/Convenience Stores in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Medicated Confectionery value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Lozenges
1.2.3 Chewable Tablets
1.2.4 Gummy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmacies/Drugstores
1.3.3 Supermarkets/Convenience Stores
1.3.4 Health & Wellness Stores
1.3.5 Hospital/Clinic Pharmacies
1.3.6 Online Retailers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medicated Confectionery Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Medicated Confectionery Revenue Market Share by Region (2020-2025)
2.4 Global Medicated Confectionery Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Medicated Confectionery Market Size and Prospective (2020-2031)
2.5.2 Europe Medicated Confectionery Market Size and Prospective (2020-2031)
2.5.3 China Medicated Confectionery Market Size and Prospective (2020-2031)
2.5.4 Japan Medicated Confectionery Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Medicated Confectionery Historic Market Size by Type (2020-2025)
3.2 Global Medicated Confectionery Forecasted Market Size by Type (2026-2031)
3.3 Different Types Medicated Confectionery Representative Players
4 Breakdown Data by Application
4.1 Global Medicated Confectionery Historic Market Size by Application (2020-2025)
4.2 Global Medicated Confectionery Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Medicated Confectionery Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Medicated Confectionery Players by Revenue (2020-2025)
5.1.2 Global Medicated Confectionery Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Medicated Confectionery Revenue
5.4 Global Medicated Confectionery Market Concentration Analysis
5.4.1 Global Medicated Confectionery Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Medicated Confectionery Revenue in 2024
5.5 Global Key Players of Medicated Confectionery Head office and Area Served
5.6 Global Key Players of Medicated Confectionery, Product and Application
5.7 Global Key Players of Medicated Confectionery, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Medicated Confectionery Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Medicated Confectionery Market Size by Type (2020-2025)
6.1.2.2 North America Medicated Confectionery Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Medicated Confectionery Market Size by Application (2020-2025)
6.1.3.2 North America Medicated Confectionery Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Medicated Confectionery Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Medicated Confectionery Market Size by Type (2020-2025)
6.2.2.2 Europe Medicated Confectionery Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Medicated Confectionery Market Size by Application (2020-2025)
6.2.3.2 Europe Medicated Confectionery Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Medicated Confectionery Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Medicated Confectionery Market Size by Type (2020-2025)
6.3.2.2 China Medicated Confectionery Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Medicated Confectionery Market Size by Application (2020-2025)
6.3.3.2 China Medicated Confectionery Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Medicated Confectionery Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Medicated Confectionery Market Size by Type (2020-2025)
6.4.2.2 Japan Medicated Confectionery Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Medicated Confectionery Market Size by Application (2020-2025)
6.4.3.2 Japan Medicated Confectionery Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Perfetti Van Melle (Halls)
7.1.1 Perfetti Van Melle (Halls) Company Details
7.1.2 Perfetti Van Melle (Halls) Business Overview
7.1.3 Perfetti Van Melle (Halls) Medicated Confectionery Introduction
7.1.4 Perfetti Van Melle (Halls) Revenue in Medicated Confectionery Business (2020-2025)
7.1.5 Perfetti Van Melle (Halls) Recent Development
7.2 Reckitt Benckiser (Strepsils)
7.2.1 Reckitt Benckiser (Strepsils) Company Details
7.2.2 Reckitt Benckiser (Strepsils) Business Overview
7.2.3 Reckitt Benckiser (Strepsils) Medicated Confectionery Introduction
7.2.4 Reckitt Benckiser (Strepsils) Revenue in Medicated Confectionery Business (2020-2025)
7.2.5 Reckitt Benckiser (Strepsils) Recent Development
7.3 Ricola AG
7.3.1 Ricola AG Company Details
7.3.2 Ricola AG Business Overview
7.3.3 Ricola AG Medicated Confectionery Introduction
7.3.4 Ricola AG Revenue in Medicated Confectionery Business (2020-2025)
7.3.5 Ricola AG Recent Development
7.4 Jakemans
7.4.1 Jakemans Company Details
7.4.2 Jakemans Business Overview
7.4.3 Jakemans Medicated Confectionery Introduction
7.4.4 Jakemans Revenue in Medicated Confectionery Business (2020-2025)
7.4.5 Jakemans Recent Development
7.5 Wrigley Company
7.5.1 Wrigley Company Company Details
7.5.2 Wrigley Company Business Overview
7.5.3 Wrigley Company Medicated Confectionery Introduction
7.5.4 Wrigley Company Revenue in Medicated Confectionery Business (2020-2025)
7.5.5 Wrigley Company Recent Development
7.6 Mondelez International (Ernest Jackson)
7.6.1 Mondelez International (Ernest Jackson) Company Details
7.6.2 Mondelez International (Ernest Jackson) Business Overview
7.6.3 Mondelez International (Ernest Jackson) Medicated Confectionery Introduction
7.6.4 Mondelez International (Ernest Jackson) Revenue in Medicated Confectionery Business (2020-2025)
7.6.5 Mondelez International (Ernest Jackson) Recent Development
7.7 Nestle
7.7.1 Nestle Company Details
7.7.2 Nestle Business Overview
7.7.3 Nestle Medicated Confectionery Introduction
7.7.4 Nestle Revenue in Medicated Confectionery Business (2020-2025)
7.7.5 Nestle Recent Development
7.8 Procter & Gamble
7.8.1 Procter & Gamble Company Details
7.8.2 Procter & Gamble Business Overview
7.8.3 Procter & Gamble Medicated Confectionery Introduction
7.8.4 Procter & Gamble Revenue in Medicated Confectionery Business (2020-2025)
7.8.5 Procter & Gamble Recent Development
7.9 Meda Pharmaceuticals
7.9.1 Meda Pharmaceuticals Company Details
7.9.2 Meda Pharmaceuticals Business Overview
7.9.3 Meda Pharmaceuticals Medicated Confectionery Introduction
7.9.4 Meda Pharmaceuticals Revenue in Medicated Confectionery Business (2020-2025)
7.9.5 Meda Pharmaceuticals Recent Development
7.10 UHA Mikakuto
7.10.1 UHA Mikakuto Company Details
7.10.2 UHA Mikakuto Business Overview
7.10.3 UHA Mikakuto Medicated Confectionery Introduction
7.10.4 UHA Mikakuto Revenue in Medicated Confectionery Business (2020-2025)
7.10.5 UHA Mikakuto Recent Development
7.11 Herbion International
7.11.1 Herbion International Company Details
7.11.2 Herbion International Business Overview
7.11.3 Herbion International Medicated Confectionery Introduction
7.11.4 Herbion International Revenue in Medicated Confectionery Business (2020-2025)
7.11.5 Herbion International Recent Development
7.12 HEXOS
7.12.1 HEXOS Company Details
7.12.2 HEXOS Business Overview
7.12.3 HEXOS Medicated Confectionery Introduction
7.12.4 HEXOS Revenue in Medicated Confectionery Business (2020-2025)
7.12.5 HEXOS Recent Development
7.13 Lofthouse of Fleetwood
7.13.1 Lofthouse of Fleetwood Company Details
7.13.2 Lofthouse of Fleetwood Business Overview
7.13.3 Lofthouse of Fleetwood Medicated Confectionery Introduction
7.13.4 Lofthouse of Fleetwood Revenue in Medicated Confectionery Business (2020-2025)
7.13.5 Lofthouse of Fleetwood Recent Development
7.14 Läkerol
7.14.1 Läkerol Company Details
7.14.2 Läkerol Business Overview
7.14.3 Läkerol Medicated Confectionery Introduction
7.14.4 Läkerol Revenue in Medicated Confectionery Business (2020-2025)
7.14.5 Läkerol Recent Development
7.15 Luden's
7.15.1 Luden's Company Details
7.15.2 Luden's Business Overview
7.15.3 Luden's Medicated Confectionery Introduction
7.15.4 Luden's Revenue in Medicated Confectionery Business (2020-2025)
7.15.5 Luden's Recent Development
7.16 Olbas
7.16.1 Olbas Company Details
7.16.2 Olbas Business Overview
7.16.3 Olbas Medicated Confectionery Introduction
7.16.4 Olbas Revenue in Medicated Confectionery Business (2020-2025)
7.16.5 Olbas Recent Development
7.17 Baker Perkins Limited
7.17.1 Baker Perkins Limited Company Details
7.17.2 Baker Perkins Limited Business Overview
7.17.3 Baker Perkins Limited Medicated Confectionery Introduction
7.17.4 Baker Perkins Limited Revenue in Medicated Confectionery Business (2020-2025)
7.17.5 Baker Perkins Limited Recent Development
8 Medicated Confectionery Market Dynamics
8.1 Medicated Confectionery Industry Trends
8.2 Medicated Confectionery Market Drivers
8.3 Medicated Confectionery Market Challenges
8.4 Medicated Confectionery Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Medicated Confectionery market size was US$ 6914 million in 2025 and is forecast to reach a readjusted size of US$ 9810 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 104
USD 4250.00
(Single User License)
The global Medicated Confectionery market is projected to grow from US$ 6914 million in 2025 to US$ 9810 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 158
USD 4900.00
(Single User License)
The global market for Medicated Confectionery was estimated to be worth US$ 6914 million in 2025 and is projected to reach US$ 9810 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 126
USD 3950.00
(Single User License)
The global Medicated Confectionery market was valued at US$ 6914 million in 2025 and is anticipated to reach US$ 9810 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 138
USD 2900.00
(Single User License)
The global market for Medicated Confectionery was estimated to be worth US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 134
USD 3950.00
(Single User License)
The global Medicated Confectionery market is projected to grow from US$ 6520 million in 2024 to US$ 9372 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-13
Pages: 158
USD 4900.00
(Single User License)
The global market for Medicated Confectionery was valued at US$ 6520 million in the year 2024 and is projected to reach a revised size of US$ 9372 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-09-13
Pages: 96
USD 2900.00
(Single User License)
The global market for Medicated Confectionery was estimated to be worth US$ 8852 million in 2024 and is forecast to a readjusted size of US$ 10590 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 132
USD 3950.00
(Single User License)
The global Medicated Confectionery market is projected to grow from US$ 8647.2 million in 2024 to US$ 10100 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period.
Published Date: 2024-04-15
Pages: 119
USD 4900.00
(Single User License)
The global market for Medicated Confectionery was estimated to be worth US$ 8398.5 million in 2023 and is forecast to a readjusted size of US$ 10100 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030
Published Date: 2024-01-16
Pages: 144
USD 3950.00
(Single User License)
The global Medicated Confectionery market size was US$ 6914 million in 2025 and is forecast to reach a readjusted size of US$ 9810 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 104
The global Medicated Confectionery market is projected to grow from US$ 6914 million in 2025 to US$ 9810 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 158
The global market for Medicated Confectionery was estimated to be worth US$ 6914 million in 2025 and is projected to reach US$ 9810 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 126
The global Medicated Confectionery market was valued at US$ 6914 million in 2025 and is anticipated to reach US$ 9810 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 138
The global market for Medicated Confectionery was estimated to be worth US$ 6520 million in 2024 and is forecast to a readjusted size of US$ 9372 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 134
The global Medicated Confectionery market is projected to grow from US$ 6520 million in 2024 to US$ 9372 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-13
Pages: 158
The global market for Medicated Confectionery was valued at US$ 6520 million in the year 2024 and is projected to reach a revised size of US$ 9372 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-09-13
Pages: 96
The global market for Medicated Confectionery was estimated to be worth US$ 8852 million in 2024 and is forecast to a readjusted size of US$ 10590 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 132
The global Medicated Confectionery market is projected to grow from US$ 8647.2 million in 2024 to US$ 10100 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period.
Published: 2024-04-15
Pages: 119
The global market for Medicated Confectionery was estimated to be worth US$ 8398.5 million in 2023 and is forecast to a readjusted size of US$ 10100 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030
Published: 2024-01-16
Pages: 144
REPORT COVERAGE
DESCRIPTION
KEY DRIVERS
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now